Bicycle Therapeutics PLC
NASDAQ:BCYC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Bicycle Therapeutics PLC
Other Non-Cash Items
Bicycle Therapeutics PLC
Other Non-Cash Items Peer Comparison
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Other Non-Cash Items
$33.8m
|
CAGR 3-Years
59%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Other Non-Cash Items
$33.4m
|
CAGR 3-Years
286%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Exscientia PLC
NASDAQ:EXAI
|
Other Non-Cash Items
ÂŁ12.6m
|
CAGR 3-Years
64%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Other Non-Cash Items
$56.9m
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Other Non-Cash Items
ÂŁ48.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Other Non-Cash Items
ÂŁ6.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
0%
|
See Also
What is Bicycle Therapeutics PLC's Other Non-Cash Items?
Other Non-Cash Items
33.8m
USD
Based on the financial report for Mar 31, 2024, Bicycle Therapeutics PLC's Other Non-Cash Items amounts to 33.8m USD.
What is Bicycle Therapeutics PLC's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
47%
Over the last year, the Other Non-Cash Items growth was 30%. The average annual Other Non-Cash Items growth rates for Bicycle Therapeutics PLC have been 59% over the past three years , 47% over the past five years .